Mr. Leopoldo Zambeletti serves as Non-Executive Director at Philogen, Nogra Pharma, DS Biopharma and The Meatless Farm. he serves as Board Member at LenioBio. During a 19-year career as an investment banker, Mr. Zambeletti led the European Healthcare Investment Banking team at JP Morgan for eight years before taking up the same position at Credit Suisse for a further five years. Since 2013 he has been an independent strategic advisor to life science companies on mergers and acquisitions, out-licensing deals and financing strategy. Mr. Zambeletti started his career at KPMG as an auditor. Mr. Zambeletti received a BA in Business from Bocconi University in Milan, Italy. Mr. Zambeletti was appointed as a Non-Executive Director of the Company in September 2015.